Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Insulin receptor-mediated cell-specific effects of GLP-1 receptor agonists in mouse model of restenosis
FY 2023-24
Summary
Atherosclerosis is the leading cause of mortality via cardiovascular diseases. One of its treatments include percutaneous transluminal coronary angioplasty, in-stent procedure to reduce vessel blockage. Such processes could cause restenosis, an acute repair process in response to injury. Although drug-eluting stents have decreased occurrence of restenosis, those with type-2 diabetes remain at risk. Our lab found that exogenous insulin has an anti-restenotic effect in murine models of restenosis (femoral-artery injury). This is abolished in mice endothelial (EC) and vascular smooth muscle (VSMC) cell insulin receptor (IR) knockouts fed with low-fat diet (LFD). However, there is no change in similar mice fed high-fat diet (HFSD). This may be due to insulin resistance. Therefore, we hypothesize that GLP-1 receptor agonists (liraglutide), which increase insulin secretion and have shown vasculoprotective effects mediated by endothelial nitric-oxide synthase (eNOS) like insulin will maintain IR-mediated protective effects, through insulin, on restenosis in HFSD mice. We will use tamoxifen-induced EC- and VSMC-specific IR knockout mice models of restenosis. Liraglutide will be used to see how neointimal growth (restenosis marker) changes. We hypothesize that wild-type mice fed on LFD and HFSD will show decrease in neointimal growth, whereas this effect will be abolished in both IR knockout mice irrespective of diet.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
505920
Name
Chaudhry Talha A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Insulin receptor-mediated cell-specific effects of GLP-1 receptor agonists in mouse model of restenosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Endothelial Cells; Femoral Artery Injury; Glp-1-Like Agonists (Liraglutide); Insulin; Insulin Receptor; Insulin Resistance; Restenosis; Type 2 Diabetes Mellitus; Vascular Smooth Muscle Celles
Abstract
Atherosclerosis is the leading cause of mortality via cardiovascular diseases. One of its treatments include percutaneous transluminal coronary angioplasty, in-stent procedure to reduce vessel blockage. Such processes could cause restenosis, an acute repair process in response to injury. Although drug-eluting stents have decreased occurrence of restenosis, those with type-2 diabetes remain at risk. Our lab found that exogenous insulin has an anti-restenotic effect in murine models of restenosis (femoral-artery injury). This is abolished in mice endothelial (EC) and vascular smooth muscle (VSMC) cell insulin receptor (IR) knockouts fed with low-fat diet (LFD). However, there is no change in similar mice fed high-fat diet (HFSD). This may be due to insulin resistance. Therefore, we hypothesize that GLP-1 receptor agonists (liraglutide), which increase insulin secretion and have shown vasculoprotective effects mediated by endothelial nitric-oxide synthase (eNOS) like insulin will maintain IR-mediated protective effects, through insulin, on restenosis in HFSD mice. We will use tamoxifen-induced EC- and VSMC-specific IR knockout mice models of restenosis. Liraglutide will be used to see how neointimal growth (restenosis marker) changes. We hypothesize that wild-type mice fed on LFD and HFSD will show decrease in neointimal growth, whereas this effect will be abolished in both IR knockout mice irrespective of diet.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chaudhry, Talha A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~